img

Global Medications for Chronic Pain Treatment Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Medications for Chronic Pain Treatment Market Insights, Forecast to 2034

Medications for chronic pain treatment are pharmaceutical drugs prescribed by healthcare professionals to manage persistent and long-lasting pain conditions. Chronic pain is often defined as pain that persists for three months or longer and can result from various underlying causes, including injury, illness, or medical conditions. The goal of chronic pain medication is to alleviate pain, improve the patient's quality of life, and enhance their ability to function.
Market Analysis and InsightsGlobal Medications for Chronic Pain Treatment Market
Global Medications for Chronic Pain Treatment market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Medications for Chronic Pain Treatment industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Medications for Chronic Pain Treatment market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Medications for Chronic Pain Treatment market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer
Abbott Laboratories
Novartis AG
Johnson and Johnson Services Inc.
YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD.
BAYER
Jiangsu Hengrui Medicine Co,.Ltd
REYOUNG
Southwest Pharmaceutical Co., Ltd.
Depomed
Endo International plc.
Purdue Pharma L.P.
AstraZeneca plc.
Merck & Co.
GlaxoSmithKline plc.
Teva Pharmaceutical Industries Ltd.
Segment by Type
Nonopioid
Opioids

Segment by Application


Hospital
Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Medications for Chronic Pain Treatment introduction, etc. Medications for Chronic Pain Treatment Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Medications for Chronic Pain Treatment
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medications for Chronic Pain Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Nonopioid
1.2.3 Opioids
1.3 Market by Application
1.3.1 Global Medications for Chronic Pain Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medications for Chronic Pain Treatment Market Perspective (2018-2029)
2.2 Global Medications for Chronic Pain Treatment Growth Trends by Region
2.2.1 Medications for Chronic Pain Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Medications for Chronic Pain Treatment Historic Market Size by Region (2018-2024)
2.2.3 Medications for Chronic Pain Treatment Forecasted Market Size by Region (2024-2029)
2.3 Medications for Chronic Pain Treatment Market Dynamics
2.3.1 Medications for Chronic Pain Treatment Industry Trends
2.3.2 Medications for Chronic Pain Treatment Market Drivers
2.3.3 Medications for Chronic Pain Treatment Market Challenges
2.3.4 Medications for Chronic Pain Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Medications for Chronic Pain Treatment by Players
3.1.1 Global Medications for Chronic Pain Treatment Revenue by Players (2018-2024)
3.1.2 Global Medications for Chronic Pain Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Medications for Chronic Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Medications for Chronic Pain Treatment, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Medications for Chronic Pain Treatment Market Concentration Ratio
3.4.1 Global Medications for Chronic Pain Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medications for Chronic Pain Treatment Revenue in 2022
3.5 Global Key Players of Medications for Chronic Pain Treatment Head office and Area Served
3.6 Global Key Players of Medications for Chronic Pain Treatment, Product and Application
3.7 Global Key Players of Medications for Chronic Pain Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Medications for Chronic Pain Treatment Breakdown Data by Type
4.1 Global Medications for Chronic Pain Treatment Historic Market Size by Type (2018-2024)
4.2 Global Medications for Chronic Pain Treatment Forecasted Market Size by Type (2024-2029)
5 Medications for Chronic Pain Treatment Breakdown Data by Application
5.1 Global Medications for Chronic Pain Treatment Historic Market Size by Application (2018-2024)
5.2 Global Medications for Chronic Pain Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Medications for Chronic Pain Treatment Market Size (2018-2029)
6.2 North America Medications for Chronic Pain Treatment Market Size by Type
6.2.1 North America Medications for Chronic Pain Treatment Market Size by Type (2018-2024)
6.2.2 North America Medications for Chronic Pain Treatment Market Size by Type (2024-2029)
6.2.3 North America Medications for Chronic Pain Treatment Market Share by Type (2018-2029)
6.3 North America Medications for Chronic Pain Treatment Market Size by Application
6.3.1 North America Medications for Chronic Pain Treatment Market Size by Application (2018-2024)
6.3.2 North America Medications for Chronic Pain Treatment Market Size by Application (2024-2029)
6.3.3 North America Medications for Chronic Pain Treatment Market Share by Application (2018-2029)
6.4 North America Medications for Chronic Pain Treatment Market Size by Country
6.4.1 North America Medications for Chronic Pain Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Medications for Chronic Pain Treatment Market Size by Country (2018-2024)
6.4.3 North America Medications for Chronic Pain Treatment Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Medications for Chronic Pain Treatment Market Size (2018-2029)
7.2 Europe Medications for Chronic Pain Treatment Market Size by Type
7.2.1 Europe Medications for Chronic Pain Treatment Market Size by Type (2018-2024)
7.2.2 Europe Medications for Chronic Pain Treatment Market Size by Type (2024-2029)
7.2.3 Europe Medications for Chronic Pain Treatment Market Share by Type (2018-2029)
7.3 Europe Medications for Chronic Pain Treatment Market Size by Application
7.3.1 Europe Medications for Chronic Pain Treatment Market Size by Application (2018-2024)
7.3.2 Europe Medications for Chronic Pain Treatment Market Size by Application (2024-2029)
7.3.3 Europe Medications for Chronic Pain Treatment Market Share by Application (2018-2029)
7.4 Europe Medications for Chronic Pain Treatment Market Size by Country
7.4.1 Europe Medications for Chronic Pain Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Medications for Chronic Pain Treatment Market Size by Country (2018-2024)
7.4.3 Europe Medications for Chronic Pain Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Medications for Chronic Pain Treatment Market Size (2018-2029)
8.2 China Medications for Chronic Pain Treatment Market Size by Type
8.2.1 China Medications for Chronic Pain Treatment Market Size by Type (2018-2024)
8.2.2 China Medications for Chronic Pain Treatment Market Size by Type (2024-2029)
8.2.3 China Medications for Chronic Pain Treatment Market Share by Type (2018-2029)
8.3 China Medications for Chronic Pain Treatment Market Size by Application
8.3.1 China Medications for Chronic Pain Treatment Market Size by Application (2018-2024)
8.3.2 China Medications for Chronic Pain Treatment Market Size by Application (2024-2029)
8.3.3 China Medications for Chronic Pain Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Medications for Chronic Pain Treatment Market Size (2018-2029)
9.2 Asia Medications for Chronic Pain Treatment Market Size by Type
9.2.1 Asia Medications for Chronic Pain Treatment Market Size by Type (2018-2024)
9.2.2 Asia Medications for Chronic Pain Treatment Market Size by Type (2024-2029)
9.2.3 Asia Medications for Chronic Pain Treatment Market Share by Type (2018-2029)
9.3 Asia Medications for Chronic Pain Treatment Market Size by Application
9.3.1 Asia Medications for Chronic Pain Treatment Market Size by Application (2018-2024)
9.3.2 Asia Medications for Chronic Pain Treatment Market Size by Application (2024-2029)
9.3.3 Asia Medications for Chronic Pain Treatment Market Share by Application (2018-2029)
9.4 Asia Medications for Chronic Pain Treatment Market Size by Region
9.4.1 Asia Medications for Chronic Pain Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Medications for Chronic Pain Treatment Market Size by Region (2018-2024)
9.4.3 Asia Medications for Chronic Pain Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Medications for Chronic Pain Treatment Introduction
11.1.4 Pfizer Revenue in Medications for Chronic Pain Treatment Business (2018-2024)
11.1.5 Pfizer Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Medications for Chronic Pain Treatment Introduction
11.2.4 Abbott Laboratories Revenue in Medications for Chronic Pain Treatment Business (2018-2024)
11.2.5 Abbott Laboratories Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Medications for Chronic Pain Treatment Introduction
11.3.4 Novartis AG Revenue in Medications for Chronic Pain Treatment Business (2018-2024)
11.3.5 Novartis AG Recent Developments
11.4 Johnson and Johnson Services Inc.
11.4.1 Johnson and Johnson Services Inc. Company Details
11.4.2 Johnson and Johnson Services Inc. Business Overview
11.4.3 Johnson and Johnson Services Inc. Medications for Chronic Pain Treatment Introduction
11.4.4 Johnson and Johnson Services Inc. Revenue in Medications for Chronic Pain Treatment Business (2018-2024)
11.4.5 Johnson and Johnson Services Inc. Recent Developments
11.5 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD.
11.5.1 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Company Details
11.5.2 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Business Overview
11.5.3 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Medications for Chronic Pain Treatment Introduction
11.5.4 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Revenue in Medications for Chronic Pain Treatment Business (2018-2024)
11.5.5 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Recent Developments
11.6 BAYER
11.6.1 BAYER Company Details
11.6.2 BAYER Business Overview
11.6.3 BAYER Medications for Chronic Pain Treatment Introduction
11.6.4 BAYER Revenue in Medications for Chronic Pain Treatment Business (2018-2024)
11.6.5 BAYER Recent Developments
11.7 Jiangsu Hengrui Medicine Co,.Ltd
11.7.1 Jiangsu Hengrui Medicine Co,.Ltd Company Details
11.7.2 Jiangsu Hengrui Medicine Co,.Ltd Business Overview
11.7.3 Jiangsu Hengrui Medicine Co,.Ltd Medications for Chronic Pain Treatment Introduction
11.7.4 Jiangsu Hengrui Medicine Co,.Ltd Revenue in Medications for Chronic Pain Treatment Business (2018-2024)
11.7.5 Jiangsu Hengrui Medicine Co,.Ltd Recent Developments
11.8 REYOUNG
11.8.1 REYOUNG Company Details
11.8.2 REYOUNG Business Overview
11.8.3 REYOUNG Medications for Chronic Pain Treatment Introduction
11.8.4 REYOUNG Revenue in Medications for Chronic Pain Treatment Business (2018-2024)
11.8.5 REYOUNG Recent Developments
11.9 Southwest Pharmaceutical Co., Ltd.
11.9.1 Southwest Pharmaceutical Co., Ltd. Company Details
11.9.2 Southwest Pharmaceutical Co., Ltd. Business Overview
11.9.3 Southwest Pharmaceutical Co., Ltd. Medications for Chronic Pain Treatment Introduction
11.9.4 Southwest Pharmaceutical Co., Ltd. Revenue in Medications for Chronic Pain Treatment Business (2018-2024)
11.9.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
11.10 Depomed
11.10.1 Depomed Company Details
11.10.2 Depomed Business Overview
11.10.3 Depomed Medications for Chronic Pain Treatment Introduction
11.10.4 Depomed Revenue in Medications for Chronic Pain Treatment Business (2018-2024)
11.10.5 Depomed Recent Developments
11.11 Endo International plc.
11.11.1 Endo International plc. Company Details
11.11.2 Endo International plc. Business Overview
11.11.3 Endo International plc. Medications for Chronic Pain Treatment Introduction
11.11.4 Endo International plc. Revenue in Medications for Chronic Pain Treatment Business (2018-2024)
11.11.5 Endo International plc. Recent Developments
11.12 Purdue Pharma L.P.
11.12.1 Purdue Pharma L.P. Company Details
11.12.2 Purdue Pharma L.P. Business Overview
11.12.3 Purdue Pharma L.P. Medications for Chronic Pain Treatment Introduction
11.12.4 Purdue Pharma L.P. Revenue in Medications for Chronic Pain Treatment Business (2018-2024)
11.12.5 Purdue Pharma L.P. Recent Developments
11.13 AstraZeneca plc.
11.13.1 AstraZeneca plc. Company Details
11.13.2 AstraZeneca plc. Business Overview
11.13.3 AstraZeneca plc. Medications for Chronic Pain Treatment Introduction
11.13.4 AstraZeneca plc. Revenue in Medications for Chronic Pain Treatment Business (2018-2024)
11.13.5 AstraZeneca plc. Recent Developments
11.14 Merck & Co.
11.14.1 Merck & Co. Company Details
11.14.2 Merck & Co. Business Overview
11.14.3 Merck & Co. Medications for Chronic Pain Treatment Introduction
11.14.4 Merck & Co. Revenue in Medications for Chronic Pain Treatment Business (2018-2024)
11.14.5 Merck & Co. Recent Developments
11.15 GlaxoSmithKline plc.
11.15.1 GlaxoSmithKline plc. Company Details
11.15.2 GlaxoSmithKline plc. Business Overview
11.15.3 GlaxoSmithKline plc. Medications for Chronic Pain Treatment Introduction
11.15.4 GlaxoSmithKline plc. Revenue in Medications for Chronic Pain Treatment Business (2018-2024)
11.15.5 GlaxoSmithKline plc. Recent Developments
11.16 Teva Pharmaceutical Industries Ltd.
11.16.1 Teva Pharmaceutical Industries Ltd. Company Details
11.16.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.16.3 Teva Pharmaceutical Industries Ltd. Medications for Chronic Pain Treatment Introduction
11.16.4 Teva Pharmaceutical Industries Ltd. Revenue in Medications for Chronic Pain Treatment Business (2018-2024)
11.16.5 Teva Pharmaceutical Industries Ltd. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Medications for Chronic Pain Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Nonopioid
Table 3. Key Players of Opioids
Table 4. Global Medications for Chronic Pain Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Medications for Chronic Pain Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Medications for Chronic Pain Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Medications for Chronic Pain Treatment Market Share by Region (2018-2024)
Table 8. Global Medications for Chronic Pain Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Medications for Chronic Pain Treatment Market Share by Region (2024-2029)
Table 10. Medications for Chronic Pain Treatment Market Trends
Table 11. Medications for Chronic Pain Treatment Market Drivers
Table 12. Medications for Chronic Pain Treatment Market Challenges
Table 13. Medications for Chronic Pain Treatment Market Restraints
Table 14. Global Medications for Chronic Pain Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Medications for Chronic Pain Treatment Revenue Share by Players (2018-2024)
Table 16. Global Top Medications for Chronic Pain Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medications for Chronic Pain Treatment as of 2022)
Table 17. Global Medications for Chronic Pain Treatment Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Medications for Chronic Pain Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Medications for Chronic Pain Treatment, Headquarters and Area Served
Table 20. Global Key Players of Medications for Chronic Pain Treatment, Product and Application
Table 21. Global Key Players of Medications for Chronic Pain Treatment, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Medications for Chronic Pain Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Medications for Chronic Pain Treatment Revenue Market Share by Type (2018-2024)
Table 25. Global Medications for Chronic Pain Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Medications for Chronic Pain Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global Medications for Chronic Pain Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Medications for Chronic Pain Treatment Revenue Share by Application (2018-2024)
Table 29. Global Medications for Chronic Pain Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Medications for Chronic Pain Treatment Revenue Share by Application (2024-2029)
Table 31. North America Medications for Chronic Pain Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Medications for Chronic Pain Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Medications for Chronic Pain Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Medications for Chronic Pain Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Medications for Chronic Pain Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Medications for Chronic Pain Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Medications for Chronic Pain Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Medications for Chronic Pain Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Medications for Chronic Pain Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Medications for Chronic Pain Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Medications for Chronic Pain Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Medications for Chronic Pain Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Medications for Chronic Pain Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Medications for Chronic Pain Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Medications for Chronic Pain Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Medications for Chronic Pain Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Medications for Chronic Pain Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Medications for Chronic Pain Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Medications for Chronic Pain Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Medications for Chronic Pain Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Medications for Chronic Pain Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Medications for Chronic Pain Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Medications for Chronic Pain Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Medications for Chronic Pain Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Medications for Chronic Pain Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Medications for Chronic Pain Treatment Product
Table 66. Pfizer Revenue in Medications for Chronic Pain Treatment Business (2018-2024) & (US$ Million)
Table 67. Pfizer Recent Developments
Table 68. Abbott Laboratories Company Details
Table 69. Abbott Laboratories Business Overview
Table 70. Abbott Laboratories Medications for Chronic Pain Treatment Product
Table 71. Abbott Laboratories Revenue in Medications for Chronic Pain Treatment Business (2018-2024) & (US$ Million)
Table 72. Abbott Laboratories Recent Developments
Table 73. Novartis AG Company Details
Table 74. Novartis AG Business Overview
Table 75. Novartis AG Medications for Chronic Pain Treatment Product
Table 76. Novartis AG Revenue in Medications for Chronic Pain Treatment Business (2018-2024) & (US$ Million)
Table 77. Novartis AG Recent Developments
Table 78. Johnson and Johnson Services Inc. Company Details
Table 79. Johnson and Johnson Services Inc. Business Overview
Table 80. Johnson and Johnson Services Inc. Medications for Chronic Pain Treatment Product
Table 81. Johnson and Johnson Services Inc. Revenue in Medications for Chronic Pain Treatment Business (2018-2024) & (US$ Million)
Table 82. Johnson and Johnson Services Inc. Recent Developments
Table 83. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Company Details
Table 84. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Business Overview
Table 85. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Medications for Chronic Pain Treatment Product
Table 86. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Revenue in Medications for Chronic Pain Treatment Business (2018-2024) & (US$ Million)
Table 87. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Recent Developments
Table 88. BAYER Company Details
Table 89. BAYER Business Overview
Table 90. BAYER Medications for Chronic Pain Treatment Product
Table 91. BAYER Revenue in Medications for Chronic Pain Treatment Business (2018-2024) & (US$ Million)
Table 92. BAYER Recent Developments
Table 93. Jiangsu Hengrui Medicine Co,.Ltd Company Details
Table 94. Jiangsu Hengrui Medicine Co,.Ltd Business Overview
Table 95. Jiangsu Hengrui Medicine Co,.Ltd Medications for Chronic Pain Treatment Product
Table 96. Jiangsu Hengrui Medicine Co,.Ltd Revenue in Medications for Chronic Pain Treatment Business (2018-2024) & (US$ Million)
Table 97. Jiangsu Hengrui Medicine Co,.Ltd Recent Developments
Table 98. REYOUNG Company Details
Table 99. REYOUNG Business Overview
Table 100. REYOUNG Medications for Chronic Pain Treatment Product
Table 101. REYOUNG Revenue in Medications for Chronic Pain Treatment Business (2018-2024) & (US$ Million)
Table 102. REYOUNG Recent Developments
Table 103. Southwest Pharmaceutical Co., Ltd. Company Details
Table 104. Southwest Pharmaceutical Co., Ltd. Business Overview
Table 105. Southwest Pharmaceutical Co., Ltd. Medications for Chronic Pain Treatment Product
Table 106. Southwest Pharmaceutical Co., Ltd. Revenue in Medications for Chronic Pain Treatment Business (2018-2024) & (US$ Million)
Table 107. Southwest Pharmaceutical Co., Ltd. Recent Developments
Table 108. Depomed Company Details
Table 109. Depomed Business Overview
Table 110. Depomed Medications for Chronic Pain Treatment Product
Table 111. Depomed Revenue in Medications for Chronic Pain Treatment Business (2018-2024) & (US$ Million)
Table 112. Depomed Recent Developments
Table 113. Endo International plc. Company Details
Table 114. Endo International plc. Business Overview
Table 115. Endo International plc. Medications for Chronic Pain Treatment Product
Table 116. Endo International plc. Revenue in Medications for Chronic Pain Treatment Business (2018-2024) & (US$ Million)
Table 117. Endo International plc. Recent Developments
Table 118. Purdue Pharma L.P. Company Details
Table 119. Purdue Pharma L.P. Business Overview
Table 120. Purdue Pharma L.P. Medications for Chronic Pain Treatment Product
Table 121. Purdue Pharma L.P. Revenue in Medications for Chronic Pain Treatment Business (2018-2024) & (US$ Million)
Table 122. Purdue Pharma L.P. Recent Developments
Table 123. AstraZeneca plc. Company Details
Table 124. AstraZeneca plc. Business Overview
Table 125. AstraZeneca plc. Medications for Chronic Pain Treatment Product
Table 126. AstraZeneca plc. Revenue in Medications for Chronic Pain Treatment Business (2018-2024) & (US$ Million)
Table 127. AstraZeneca plc. Recent Developments
Table 128. Merck & Co. Company Details
Table 129. Merck & Co. Business Overview
Table 130. Merck & Co. Medications for Chronic Pain Treatment Product
Table 131. Merck & Co. Revenue in Medications for Chronic Pain Treatment Business (2018-2024) & (US$ Million)
Table 132. Merck & Co. Recent Developments
Table 133. GlaxoSmithKline plc. Company Details
Table 134. GlaxoSmithKline plc. Business Overview
Table 135. GlaxoSmithKline plc. Medications for Chronic Pain Treatment Product
Table 136. GlaxoSmithKline plc. Revenue in Medications for Chronic Pain Treatment Business (2018-2024) & (US$ Million)
Table 137. GlaxoSmithKline plc. Recent Developments
Table 138. Teva Pharmaceutical Industries Ltd. Company Details
Table 139. Teva Pharmaceutical Industries Ltd. Business Overview
Table 140. Teva Pharmaceutical Industries Ltd. Medications for Chronic Pain Treatment Product
Table 141. Teva Pharmaceutical Industries Ltd. Revenue in Medications for Chronic Pain Treatment Business (2018-2024) & (US$ Million)
Table 142. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Medications for Chronic Pain Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Medications for Chronic Pain Treatment Market Share by Type: 2022 VS 2029
Figure 3. Nonopioid Features
Figure 4. Opioids Features
Figure 5. Global Medications for Chronic Pain Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Medications for Chronic Pain Treatment Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Pharmacy Case Studies
Figure 9. Other Case Studies
Figure 10. Medications for Chronic Pain Treatment Report Years Considered
Figure 11. Global Medications for Chronic Pain Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Medications for Chronic Pain Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Medications for Chronic Pain Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global Medications for Chronic Pain Treatment Market Share by Players in 2022
Figure 15. Global Top Medications for Chronic Pain Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medications for Chronic Pain Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Medications for Chronic Pain Treatment Revenue in 2022
Figure 17. North America Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Medications for Chronic Pain Treatment Market Share by Type (2018-2029)
Figure 19. North America Medications for Chronic Pain Treatment Market Share by Application (2018-2029)
Figure 20. North America Medications for Chronic Pain Treatment Market Share by Country (2018-2029)
Figure 21. United States Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Medications for Chronic Pain Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Medications for Chronic Pain Treatment Market Share by Type (2018-2029)
Figure 25. Europe Medications for Chronic Pain Treatment Market Share by Application (2018-2029)
Figure 26. Europe Medications for Chronic Pain Treatment Market Share by Country (2018-2029)
Figure 27. Germany Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Medications for Chronic Pain Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Medications for Chronic Pain Treatment Market Share by Type (2018-2029)
Figure 35. China Medications for Chronic Pain Treatment Market Share by Application (2018-2029)
Figure 36. Asia Medications for Chronic Pain Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Medications for Chronic Pain Treatment Market Share by Type (2018-2029)
Figure 38. Asia Medications for Chronic Pain Treatment Market Share by Application (2018-2029)
Figure 39. Asia Medications for Chronic Pain Treatment Market Share by Region (2018-2029)
Figure 40. Japan Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Medications for Chronic Pain Treatment Market Share by Country (2018-2029)
Figure 50. Brazil Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Medications for Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Pfizer Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2018-2024)
Figure 57. Abbott Laboratories Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2018-2024)
Figure 58. Novartis AG Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2018-2024)
Figure 59. Johnson and Johnson Services Inc. Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2018-2024)
Figure 60. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2018-2024)
Figure 61. BAYER Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2018-2024)
Figure 62. Jiangsu Hengrui Medicine Co,.Ltd Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2018-2024)
Figure 63. REYOUNG Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2018-2024)
Figure 64. Southwest Pharmaceutical Co., Ltd. Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2018-2024)
Figure 65. Depomed Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2018-2024)
Figure 66. Endo International plc. Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2018-2024)
Figure 67. Purdue Pharma L.P. Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2018-2024)
Figure 68. AstraZeneca plc. Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2018-2024)
Figure 69. Merck & Co. Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2018-2024)
Figure 70. GlaxoSmithKline plc. Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2018-2024)
Figure 71. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2018-2024)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries